Use of A Complex Gut Bacterial Consortium (MITI 001) for the Treatment of Irritable Bowel Syndrome With Diarrhea

Clinical trial NCT07238790 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07238790
Sponsor: Stanford University
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

IBS (Irritable Bowel Syndrome)Diarrhea

Start date: 2025-12-01
Primary completion: 2028-12-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.